SERPINE1 and SERPINB7 as potential biomarkers for intravenous vitamin C treatment in non-small-cell lung cancer
Authors:
- 12 October 2023
- journal article
- research article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 209, 96-107
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Epigenetics in Personalized Management of Lung Cancer2015
- Involvement of Urokinase‐Type Plasminogen Activator System in Cancer: An OverviewMedicinal Research Reviews, 2014
- High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of ChemotherapyScience Translational Medicine, 2014
- Ascorbic Acid and a Cytostatic Inhibitor of Glycolysis Synergistically Induce Apoptosis in Non-Small Cell Lung Cancer CellsPLOS ONE, 2013
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Phase I clinical trial of i.v. ascorbic acid in advanced malignancyAnnals of Oncology, 2008
- Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivoProceedings of the National Academy of Sciences, 2007
- Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: Relation to prognosis and angiogenesisLung Cancer, 2007
- Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissuesProceedings of the National Academy of Sciences of the United States of America, 2005
- Vitamins C and E attenuate plasminogen activator inhibitor-1 (PAI-1) expression in a hypercholesterolemic porcine model of angioplastyCardiovascular Research, 2001